Robotic Radical Nephrectomy with Vena Cava Thrombus Extraction (RRN-VCTE) for Renal Cell Carcinoma: A Meta-Analysis of Surgical Technique and Outcomes
Open Access
- 5 January 2024
- journal article
- review article
- Published by Codon Publications in Journal of Kidney Cancer
- Vol. 11 (1) , 5-11
Abstract
Renal cell carcinoma (RCC) with vena cava tumor thrombus is a challenging condition, which requires complex surgical management. Robotic radical nephrectomy with vena cava thrombus extraction (RRN-VCTE) has emerged as a promising and minimally invasive technique. This meta-analysis aims to review the surgical technique and outcomes of RRN-VCTE in patients with RCC and vena cava tumor thrombus. A comprehensive literature search was conducted using databases, including PubMed, Embase, and Cochrane Library. Studies published in English till October 2021 were included. Keywords used for the search included “robotic radical nephrectomy,” “vena cava tumor thrombus,” “surgical technique,” and “outcomes.” Studies that reported on patient outcomes and surgical techniques of RRN-VCTE were included. Statistical analysis was performed to assess the pooled outcomes. The meta-analysis included 16 studies comprising 298 patients who underwent RRN-VCTE. The majority of patients were males (62.4%) with a median age of 58.9 years. The median tumor size was 7.2 cm, and 93.9% of patients had level 3 or 4 vena cava thrombus. The mean operating time was 328 min, with a range of 248–423 min. Blood loss ranged from 100 to 1500 mL. The overall complication rate was 26.5%, with no reported deaths. The average hospital stay was 9.5 days. The 2-year and 5-year survival rates were 77.5 and 53.1%, respectively. RRN-VCTE is a promising and minimally invasive surgical technique for RCC with vena cava tumor thrombus, whch is associated with low complication rates and acceptable oncological outcomes. Further research is needed to confirm the long-term survival rates and compare RRN-VCTE outcomes with conventional surgical techniques. Nonetheless, RRN-VCTE appears to be a valuable option for patients with RCC and vena cava tumor thrombus.Keywords
This publication has 29 references indexed in Scilit:
- External Validation of the Leibovich Prognosis Score for Nonmetastatic Clear Cell Renal Cell Carcinoma at a Single European Center Applying Routine PathologyJournal of Urology, 2011
- The Epidemiology of Renal Cell CarcinomaEuropean Urology, 2011
- Small Renal MassNew England Journal of Medicine, 2010
- Renal Carcinoma With Supradiaphragmatic Tumor Thrombus: Avoiding Sternotomy and Cardiopulmonary BypassThe Annals of Thoracic Surgery, 2010
- Assessing the Impact of Ischaemia Time During Partial NephrectomyEuropean Urology, 2009
- Guideline for Management of the Clinical T1 Renal MassJournal of Urology, 2009
- The R.E.N.A.L. Nephrometry Score: A Comprehensive Standardized System for Quantitating Renal Tumor Size, Location and DepthJournal of Urology, 2009
- A Prospective Randomized EORTC Intergroup Phase 3 Study Comparing the Complications of Elective Nephron-Sparing Surgery and Radical Nephrectomy for Low-Stage Renal Cell CarcinomaEuropean Urology, 2007
- RENAL CELL CARCINOMA WITH RENAL VEIN AND INFERIOR VENA CAVAL INVOLVEMENT: CLINICOPATHOLOGICAL FEATURES, SURGICAL TECHNIQUES AND OUTCOMESJournal of Urology, 2005
- Orthotopic Liver Transplantation with Preservation of the Inferior Vena CavaAnnals of Surgery, 1989